Live Younger For Longer™
Your path to a longer, healthier life is deeply personal. Our team, backed by Harvard and MIT scientists, has developed the most scientifically validated longevity solutions available today. Let our tools, knowledge, and supplements help you achieve your goals.
Our Vision
Our vision is to add a billion healthy years to humanity’s lifespan.
Longevity supplements have fallen short in delivering true anti-aging results, relying on outdated concepts, ineffective ingredients, and sub-optimal combinations and dosages. But at NOVOS, we’re changing the game.
We are pioneers in consumer longevity and the first to develop a comprehensive approach that targets all 12 mechanisms of aging simultaneously. Our patent-pending NOVOS Core formula represents a breakthrough in longevity science, backed by award-winning innovations and leading-edge research.
And our results speak for themselves. In a groundbreaking study, NOVOS Core extended aged mouse lifespan by nearly 20%—more than any supplement ever studied. Additionally, other research demonstrates that NOVOS’ ingredient combinations help maintain healthy DNA and support the body’s ability to manage senescent cells. Evidence continues to accumulate, demonstrating the efficacy of our industry-leading approach. We’ve already seen life-changing results from countless people, with over 10 million doses taken to date.
Longevity goes beyond novel formulations and taps into every aspect of life. That’s why we’ve built a comprehensive ecosystem—including supplements, at-home aging tests, and free educational resources—to help you take control of your longevity journey. We believe in a new era of longevity, where science and innovation converge helping you be Younger For Longer.
Our Story
Our founders, driven by personal health journeys and profound scientific expertise, established NOVOS with the determination to address aging at its root.
Chris Mirabile
Founder & CEO:
A serial entrepreneur and brain tumor survivor, Chris has turned his personal health challenges into catalysts for change. His journey through recovery and extensive research into longevity led him to found NOVOS. Chris’s story is one of resilience and innovation, driven by a commitment to extending longevity and quality of life for all.
Meet Our Team Of
World-Class Experts
Ordinary Customers, Extraordinary Results
Hear from everyday users who have experienced the benefits
Yes, We Have Scientific Evidence.
2 Powerful Formulas. 20 Innovative Ingredients. 500+ Studies. View our growing record of direct and indirect NOVOS studies.
In a recent study of aged mice, NOVOS Core increased lifespan by 18%, surpassing all previously studied supplements in similar research, including NAD+ boosters like nicotinamide riboside.
In just 6 months, 73% of NOVOS Core users experienced a significant reduction in their biological aging pace, with an average slowdown of 8.7% which works out to be 31.75 days younger per year. Nobody’s aging sped up.
Ingredients in NOVOS Core reduced the size of human senescent cells (cells that age and become toxic) by approximately 50% in an in-vitro study, offering effects comparable to a pharmaceutical longevity drug, rapamycin*.
After 6 months, all participants experienced increased skin firmness by an average of 22%, enhancing both appearance and feel.
NOVOS Core users ranked (#2, #5, and #7) for lowest rates of aging in a global competition that uses the DunedinPACE algorithm created by Duke and Columbia scientists to measure epigenetic changes.
Ingredients in NOVOS Core were able to prevent DNA damage by up to 77% in skin cells exposed to irradiation (e.g., UV rays) in an in-vitro study. In another human skin cell study, DNA was protected from moderate and high intensity chemo drugs.
NOVOS Core’s ingredients reduced unwanted cell death processes called oxytosis/ferroptosis, by 50%, while also reducing cellular inflammation, in an in-vitro human cellular study.
In a recent study of aged mice, NOVOS Core increased lifespan by 18%, surpassing all previously studied supplements in similar research, including NAD+ boosters like nicotinamide riboside.
In just 6 months, 73% of NOVOS Core users experienced a significant reduction in their biological aging pace, with an average slowdown of 8.7% which works out to be 31.75 days younger per year. Nobody’s aging sped up.
Ingredients in NOVOS Core reduced the size of human senescent cells (cells that age and become toxic) by approximately 50% in an in-vitro study, offering effects comparable to a pharmaceutical longevity drug, rapamycin*.
After 6 months, all participants experienced increased skin firmness by an average of 22%, enhancing both appearance and feel.
NOVOS Core users ranked (#2, #5, and #7) for lowest rates of aging in a global competition that uses the DunedinPACE algorithm created by Duke and Columbia scientists to measure epigenetic changes.
Ingredients in NOVOS Core were able to prevent DNA damage by up to 77% in skin cells exposed to irradiation (e.g., UV rays) in an in-vitro study. In another human skin cell study, DNA was protected from moderate and high intensity chemo drugs.
NOVOS Core’s ingredients reduced unwanted cell death processes called oxytosis/ferroptosis, by 50%, while also reducing cellular inflammation, in an in-vitro human cellular study.
NOVOS, established in 2018, is a pioneer in longevity, reshaping the future of aging and enabling healthier, longer lives.
2018
Vision for NOVOS; networking with scientists to validate concept and approach.
Assembly of team of Scientific Advisors; research into ingredients and biological pathways.
2019
Creation of initial prospective formulas and alpha testing with human test groups.
2020
Additional testing of formulas with human test groups. Creation of brand identity, website, and educational content.
2021
Launch beta of Core to thousands of customers.
First in vitro study results, Core reduces DNA damage from irradiation.
2022
Launch NOVOS Age.
Study finds that NOVOS Core’s synergistic ingredients reduce cellular senescence.
2023
Out of beta, officially launched.
Created Medical Advisory Board with Dr. Robert Lufkin as inaugural member.
Case study results find find NOVOS Core reduces pace of aging.
In vitro study finds NOVOS Core reduces double strand DNA breaks from chemotherapeutics.
2024
Launched NOVOS Vital for organ health.
The Salk Institute finds in an in vitro study that NOVOS Core reduces oxytosis/ferroptosis, processes associated with Alzheimer’s and dementia.
Core extends aged mouse lifespan by ~20%, more than any supplement ever studied.
Peer-reviewed study finds Core reduces DNA strand breaks in skin cells from chemotherapeutics.
Accepted into prestigious Longevity Biotechnology Association as only consumer brand.
The product that pioneered the science-based longevity movement.
Combats the 12 root causes of aging.
A commitment beyond commerce
As a Public Benefit Corporation and as part of our ongoing longevity efforts, we donate a portion of our profits and equity to nonprofits such as the 501(c)(3), Lifespan Extension Advocacy Foundation (LEAF). We’ve also partnered with the Dog Aging Project to support research that helps dogs live longer, healthier lives while advancing insights into human longevity.
NOVOS has joined the prestigious Longevity Biotechnology Association (LBA) and is the only over-the-counter, natural supplement company included in this global network of geroscience leaders. This milestone underscores our unwavering commitment to science-backed longevity solutions.
Combats the 12 root causes of aging.
Become An Insider & Stay Updated
Subscribe for exclusive insights and updates directly from the forefront of longevity science. Get the most from NOVOS with tailored advice and special promotions.
Exclusive Content
First look at breakthroughs and innovations.
Tailored Tips
Personalized health insights.
Special Offers
Subscribers-only discounts and promotions.